Clinical Research Site

Rochester, New York 14620

0 studies enrolling now · 9 studies all time

What they study most

Agitation in Patients With Dementia of the Alzheimer's Type, Depression, Major Depressive Disorder, Migraine, Schizophrenia, Treatment Resistant Depression

Studies at this site

• Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE) — Stopped early
• Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia — Stopped early
• Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
• A Trial of AXS-05 in Patients With Major Depressive Disorder — Completed
• Mechanistic Evaluation of Response in TRD (MERIT) — Completed